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Identifying Darwinian Selection Acting on Different
Human APOL1 Variants among Diverse African Populations
Wen-Ya Ko,1,2 Prianka Rajan,1 Felicia Gomez,1,3 Laura Scheinfeldt,1 Ping An,4 Cheryl A. Winkler,4
Alain Froment,5 Thomas B. Nyambo,6 Sabah A. Omar,7 Charles Wambebe,8 Alessia Ranciaro,1
Jibril B. Hirbo,1 and Sarah A. Tishkoff1,9,*
Disease susceptibility can arise as a consequence of adaptation to infectious disease. Recent findings have suggested that higher rates of
chronic kidney disease (CKD) in individuals with recent African ancestrymight be attributed to two risk alleles (G1 andG2) at the serum-
resistance-associated (SRA)-interacting-domain-encoding region of APOL1. These two alleles appear to have arisen adaptively, possibly as
a result of their protective effects against human African trypanosomiasis (HAT), or African sleeping sickness. In order to explore the
distribution of potential functional variation at APOL1, we studied nucleotide variation in 187 individuals across ten geographically
and genetically diverse African ethnic groupswith exposure to two Trypanosoma brucei subspecies that causeHAT.We observed unusually
high levels of nonsynonymous polymorphism in the regions encoding the functional domains that are required for lysing parasites.
Whereas allele frequencies of G2 were similar across all populations (3%–8%), the G1 allele was only common in the Yoruba (39%). Addi-
tionally, we identified a haplotype (termed G3) that contains a nonsynonymous change at the membrane-addressing-domain-encoding
region of APOL1 and is present in all populations except for the Yoruba. Analyses of long-range patterns of linkage disequilibrium indi-
cate evidence of recent selection acting on the G3 haplotype in Fulani from Cameroon. Our results indicate that the G1 and G2 variants
inAPOL1 are geographically restricted and that theremight be other functional variants that could play a role in HATresistance andCKD
risk in African populations.Introduction
Infectious disease is a major force of natural selection in
humans, often resulting in a high frequency of genetic
variants that are protective against infection but that
might also cause disease.1 J.B.S. Haldane phrased evolu-
tionary adaptation of this kind as ‘‘temporarily successful
acquisitions of immunity’’ owing to its cost to carriers’
health.2 A classic example is the high prevalence of hemo-
globinopathies in regions where malaria is or was endemic
as a result of their protective effects against infection.3–7
For this reason, characterization of signatures of natural
selection can be informative for identifying functionally
important genetic variation that might play a role in dis-
ease susceptibility.8,9
More recently, genetic variation in APOL1 (MIM 603743)
has been demonstrated to be associated with resistance to
human African trypanosomiasis (HAT) and with suscepti-
bility to chronic kidney disease (CKD) in African
Americans. CKD is a progressive loss of renal function
over time and affects over 14% of adults in the United
States. Severe forms of CKD are typically characterized on
the basis of clinical phenotypes such as diabetic nephrop-
athy, hypertensive nephrosclerosis, lupus nephritis, focal
segmental glomerulosclerosis (FSGS), and end-stage renal1Department of Genetics, School of Medicine, University of Pennsylvania, P
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portionally high rates among individuals of African
descent. For example, African Americans suffer from
ESRD rates that are four times higher than those in Euro-
pean Americans.10–18 Initial studies indicated that ESRD
and FSGS are strongly associated with MYH9 (nonmuscle
myosin heavy chain 9 [MIM 160775]) in chromosomal
region 22–q12 in African Americans.MYH9was considered
a strong candidate for disease risk because of its expression
in podocyte cells of the Bowman’s capsule, which wraps
around the capillaries of the renal glomerulus,19–22
although a causative variant was not identified.23 Using
sequence data from the 1000 Genomes Project to identify
MYH9-proximal variants that differ in frequency between
the Nigerian Yoruba and European populations, Genovese
et al.24 and Tzur et al.25 identified two risk alleles (termed
G1 and G2) at APOL1, located 14 kb fromMYH9, and these
alleles accounted for most of the statistical association pre-
viously attributed to the MYH9 variants.
Apolipoprotein L1, encoded by APOL1, is a serum apoli-
poprotein bound to high-density-lipoprotein (HDL) parti-
cles. APOL1 belongs to the apolipoprotein L gene family,
which is composed of six genes spanning over 619 kb on
human chromosome 22. In human blood, APOL1 is one
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Figure 1. Geographic Distribution of the Endemicity of HAT and
Sampled Populations in Sub-Saharan Africa
The map of the endemicity of HAT was adapted from the World
Health Organization Report on Global Surveillance of Epidemic-
Prone Infectious Diseases.28 The endemicity distribution ismarked
by a black line separating HAT into theWest African form, which is
caused by Trypanosoma brucei gambiense, and the East African
form, which is caused by T. b. rhodesiense.(TLF), which lyses pathogenic Trypanosoma brucei, a para-
sitic protozoa transmitted by the tsetse fly. HAT occurs in
a large geographic region including 36 sub-Saharan coun-
tries and is caused by two different T. b. subspecies, T. b.
rhodesiense and T. b. gambiense, which cause the eastern
and western forms of HAT, respectively.26 On the basis of
the lytic properties of APOL1 and the observation that
both risk alleles exist on unusually long haplotypes, a
pattern consistent with recent positive selection, Genovese
et al.24 speculated that the risk alleles associated with CKD
might have increased in allele frequency rapidly because of
their potential protective effects against HAT.
Prior studies have focused on analyzing genetic signa-
tures of selection at APOL1 in the Yoruba population
from Nigeria in western Africa.24 However, in vitro assays
of trypanolytic activity have shown that the two renal
risk alleles are resistant only to T. b. rhodesiense, which
causes the eastern form of HAT. No variants have been
found to confer resistance to T. b gambiense, which is
currently endemic in western Africa.24 Because African
populations are genetically highly substructured, it is
possible that patterns of genetic variation in APOL1might
differ in other populations.27 In this study, we sequenced a
1.4 kb APOL1 region that encompasses the last exon,
which carries the G1 and G2 alleles, in 187 individuals
from ten geographically and ethnically diverse African
populations (Figure 1). We observed unusually high levels
of nonsynonymous genetic variation with differing alleleThefrequencies and linkage-disequilibrium (LD) patterns
across sub-Saharan Africa. We analyzed patterns of nucleo-
tide variation and detected signatures of adaptive evolu-
tion on the basis of long-range haplotype homozygosity.
We further identified several variants that appear to be tar-
gets of selection, suggesting that these variants are candi-
dates for HAT resistance, as well as potential candidates
contributing to CKD susceptibility in Africans.Material and Methods
Ethnic Groups and DNA Samples
Human DNA samples were collected from 187 unrelated individ-
uals from ten different African ethnic groups, including the
Yoruba from Nigeria; the Bakola pygmy, Fulani, Lemande, and
Mada from Cameroon; the Borana and Sengwer from Kenya;
and the Hadza, Datog, Iraqw, and Sandawe from Tanzania.
Approval of the institutional review boards for our research project
was received from both the University of Maryland and the Uni-
versity of Pennsylvania. Prior to sample collection, research-ethics
permits and approval were also obtained from the Commission for
Science and Technology and the National Institute for Medical
Research in Dar es Salaam, Tanzania; the Kenya Medical Research
Institute in Nairobi, Kenya; the Nigerian Institute for Research and
Pharmacological Development in Abuja, Nigeria; and theMinistry
of Health and National Committee of Ethics in Cameroon. Writ-
ten informed consent was received from all participants. Subject
identity was anonymized.
PCR and DNA Resequencing
We resequenced the last exon (883 bp) of APOL1 and its adjacent
intron for a total of 1.4 kbof sequence (Figure2). This genetic region
was chosen because it encodes the pore-forming, membrane-
addressing, and serum-resistance-associated (SRA)-interacting
domains, which are involved in APOL1-associated trypanolysis,
andbecausevariants in this regionhavebeen foundtobeassociated
with CKD risk.24,25,29 The targeted region was amplified with the
use of several gene-specific primer pairs. PCR experimentswere per-
formed under the condition of 200 mMof dNTP (Promega), 0.2 mM
of each primer, and 1.5–2.5mMofMgSO4with the use of Platinum
Taq DNA Polymerase High Fidelity (Invitrogen). PCR cycles con-
sisted of one cycle of preincubation (94C for 1 min), 35 cycles of
amplification (95C for 30 s, 60C–64C for 30 s, and 72C for 45
s), andone cycle of extension (72C for 7min). TheMgSO4 concen-
tration and PCR annealing temperature varied among different
primer sets (see Table S1, available online, for information on
primer pairs and MgSO4 concentrations). Alkaline phosphatase
and exonuclease I (United States Biochemicals) were applied for
PCR purification, and sequencing reactions were subsequently
performed with an automated ABI 3730xl High-Throughput DNA
Sequencer (Applied Biosystems). The sequence contigswere assem-
bled and heterozygous sites were identified with the Sequencher
5.0 application (Gene Codes Corporation). Sequences obtained
for this study were submitted to the GenBank sequence database
with the accession numbers KC339295–KC339481.
Estimating Genetic Diversity, Frequency Spectra of
SNPs, and LD
All DNA sequences from 187 individuals were aligned with the
CLUSTALW algorithm implemented in the MegAlign applicationAmerican Journal of Human Genetics 93, 54–66, July 11, 2013 55
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Figure 2. Spatial Distribution of Genetic
Variants at the Functional-Domain-Encod-
ing Region of APOL1
The APOL1 genetic region, which codes
for the pore-forming (blue), membrane-
addressing (green), and SRA-interacting
(orange) domains, and the adjacent
intron are marked by genetic variants
identified in this study. Each synony-
mous and intronic SNP is labeled by
a gray line. Each nonsynonymous SNP
is labeled by a black line with its
genomic position (based on NCBI
Genome browser build 36.1) and refer-
ence SNP ID if it is described in dbSNP.
For those nonsynonymous SNPs that
are not present in dbSNP (build 137),
the changes of nucleotide state are
given according to RefSeq NG_023228.1.
The indel variant (i.e., G2 allele) is
labeled by an inverted triangle. The nucleotide site of each variant at our sequence alignment is labeled at the
bottom of the gene. The nucleotide sites that define the G3 haplotype are labeled with asterisks.(DNASTAR software package) and examined by eye. The haplo-
type sequences were inferred with PHASE version 2.1.30,31 Watter-
son’s estimate of nucleotide heterozygosity (qw) was computed for
estimating nucleotide diversity for a given population.32 We also
computed Tajima’s D statistic to characterize allele-frequency
spectra of SNPs and to test for deviation from a neutral equilib-
riummodel by contrasting the difference between p (average pair-
wise nucleotide differences) and qw (D ¼ p qw=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Varðp; qwÞ
p
).
The significance levels were determined by a null distribution
generated by a coalescent-based simulation assuming constant
population sizes over generations and no recombination for a
given observed number of segregating sites (S) and number of
sampled chromosomes. For a given variant present in more than
half of the ten populations, FST was calculated for quantifying
the levels of difference in allele frequency across populations.33
For any given pair of SNPs, LD was estimated by the squared cor-
relation coefficient, rij ¼ ðpij  pipjÞ2=pið1 piÞpjð1 pjÞ, where pij
is the frequency of one of the four possible gametic types for a
given pair of SNPs i and j and where pi and pj are the allele fre-
quencies of SNPs i and j, respectively.34 The two-tailed Fisher’s
exact test was applied for computing the probability of the
observed numbers of four gametic types under the null hypothesis
of linkage equilibrium for determining the statistical significance
of association between two given polymorphic sites. The LD
maps were plotted with the LD heatmap package written in R.35
A list of all phased haplotypes and their frequencies is provided
in Table S2.SNP Genotyping and Detecting Signatures of Recent
Darwinian Selection
Genovese et al.24 have shown that the G1 and G2 alleles at APOL1
are candidates for recent Darwinian selection in the Yoruba popu-
lation. In this study, we were also interested in the detection of
recent adaptive selection for other APOL1 variants identified in
these ten populations. Under the scenario of recent positive selec-
tion, a selection-favored variant is expected to increase its fre-
quency in a population much faster than a neutral mutation in
a considerably short period of evolutionary time. Therefore,
recombination does not occur sufficiently to break down the
haplotype that carries the selected variant and subsequently re-56 The American Journal of Human Genetics 93, 54–66, July 11, 2013sults in an unusual long-range LD haplotype in comparison with
other haplotypes that contain only neutral variants. In order to
characterize long-range LD patterns of haplotypes, we analyzed a
subset of our sampled individuals for whom we had whole-
genome SNP genotyping data. Our analyzed data were a subset
of the whole-genome SNP genotyping data generated with the Il-
lumina Human 1M-Duo DNA Analysis BeadChip (data not
shown). We combined all the APOL1 variants identified from
our resequencing efforts in this study with the SNP genotyping
data that include 1,083,730 SNPs for the entire genome (excluding
sex chromosomes) after quality control for SNP calls. Overall, 145
out of 187 individuals were included in this data set for the long-
range-haplotype LD analyses.
We first characterized the long-range LD patterns for the ances-
tral and derived alleles by calculating the extended haplotype ho-
mozygosity (EHH) for a given polymorphic site.36 We then
computed the integrated haplotype score (iHS), which summa-
rizes the differences in the observed decay of EHH between the
ancestral and derived alleles for each polymorphic site, and
compared the iHS for a given SNP of interest to the empirical
iHS distribution estimated across the genome.36,37 We first per-
formed fastPHASE (version 1.4) to phase the Illumina 1M SNPs
for each chromosome separately after adding the SNPs identified
from our resequencing effort into the SNP data for chromosome
22.38 The combined SNP data set resulted in a high density of
SNPs at APOL1’s last exon, which was our genetic region of inter-
est. We then measured decay of LD by calculating the EHH for a
given core SNP and the surrounding SNPs in the order of
increasing distances: starting with the core SNP (EHH ¼ 1) and
continuing with the next closest neighboring SNPs to the core
SNP at both proximal and distal sides. EHH statistics were calcu-
lated for all possible surrounding SNPs until the value fell under
0.05. The EHH is calculated as EHHt ¼
Ps
i¼1

eij
2

ct
2

, where
t is the core haplotype tested, c is the number of samples of a
particular core haplotype, e is the number of samples for a partic-
ular extended haplotype, and s is the number of unique extended
haplotypes according to Sabeti et al.39 The EHH was calculated for
all possible SNPs that had at least two minor allele copies in the
sample (minor allele frequency > 0.05) for a given population.
The estimated EHH values of the core and neighboring SNPs
Table 1. Minor Allele Frequencies of Nonsynonymous Variants at the Last Exon of APOL1 in African Human Populations
Site Protein Alteration
Cameroon Kenya Nigeria Tanzania
Fulani Lemande Mada Bakola Borana Sengwer Yoruba Hadza Iraqw Sandawe FST
652 p.Gly150Lys 39% 44% 39% 13% 44% 45% 14% 16% 37% 47% 0.10
731 p.Asn176Ser - 6% 11% 5% - - 11% - 3% - -
888G3 p.Met228Ile 26% 3% 3% 32% 14% 16% - 5% 16% 5% 0.098
968G3 p.Lys255Arg 26% 3% 3% 13% 8% 16% - 5% 13% 3% 0.073
996 p.Asn264Lys - 6% 5% - 8% 8% - 34% 5% - 0.15
1,001 p.Leu266Arg - - - - - 3% - - - 3% -
1,013 p.Gly270Asp - - - 5% 8% - - - 11% 8% -
1,097 p.His298Arg - - - - - - - - - 3% -
1,136 p.Ser311Leu - - - - 3% - - - - - -
1,213 p.Asp337Asn 8% 14% - 18% 14% 8% 14% 21% 21% 37% 0.046
1,228G1 p.Ser342Gly - - 3% 5% - - 39% 5% 5% 5% 0.21
1,258 p.Leu352Phe - - - - - 5% - - - - -
1,354 p.Ile384Phe - - - - - - - - 3% 5% -
1,356G1 p.Ile384Met - - 3% 5% - - 39% 5% 5% 5% 0.21
1,357 p.Leu385Phe - - - - - - - - - 3% -
1,368G2 p.Asn388_Tyr389del 8% 3% 3% 5% 3% 3% 6% - 3% - 0.017
‘‘Site’’ represents the nucleotide position of each variant in our sequence alignment (also see Figure 2). The G1, G2, and G3 variants are labeled as superscripts at
their positions. The amino acid positions are based on RefSeq NM_003661.3. FST estimates are shown only for the common variants that were observed in more
than half of the ten populations.were plotted against their genetic distances for the derived and
ancestral alleles for a given core site. An allele was determined to
be ancestral or derived with the use of gorilla and orangutan as
outgroups (APOL1 is absent from the chimpanzee genome40). In
a few cases, the rhesus macaque sequence was used as an outgroup
if the data were missing from the two great apes.
The genetic map used for calculating the iHS was taken from Jar-
vis et al.41 This fine-scale genetic map was generated from a SNP
data set including a total of 100 unrelated individuals from the
Yoruba in Ibadan, Nigeria, and the Luhya in Webuye, Kenya, in
HapMap3 Release 2 (January 2009). A composite-likelihood
method was performed for estimating the population recombina-
tion parameters (4Ner, whereNe is effective population size and r is
recombination rate per generation) between consecutive markers
with the use of LDhat as detailed in Jarvis et al.41 The area under
the EHH curves for derived and ancestral alleles can be integrated
separately, and the test statistic, iHS (unstandardized), is calculated
as ln(iHHA / iHHD), where iHHA and iHHD are integrated EHH
values for ancestral and derived alleles, respectively. The iHS test
statistic reflects the differences in the long-range LD patterns be-
tween the haplotypes carrying the ancestral and derived alleles.
The iHS estimate can be normalized on the basis of an empirical
distribution obtained from all possible SNPs whose derived allele
frequency matches the frequency at the core SNP of interest, as
described by Voight et al.37
In addition to EHH and iHS analyses, the r2 estimates of LD were
also plotted against their physical distances between all possible
pairs of polymorphic sites (with minor allele frequencyR 3% ac-
cording to Verrelli et al.42) in each population for illustrating the
decay of LD in a 30 kb region surrounding our resequenced region.
A fitted regression line was determined on the basis of nonlinearTheleast-squares estimates of the parameters of a nonlinear model,
Eðr2Þ ¼ 1=ðaþ rÞ, where r is 4Ner, according to Hudson.43Results
High Levels of Nonsynonymous Variation in APOL1
across Diverse Ethnic Groups
We resequenced a 1.4 kb region that includes APOL1’s last
exon (883 bp), which codes for three APOL1 functional do-
mains—the pore-forming, membrane-addressing, and
SRA-interacting domains—that are required for lysing try-
panosomes, and a portion (518 bp) of the adjacent intron
across 187 ethnically diverse African individuals origi-
nating from ten populations (see Figures 1 and 2). Overall,
we identified 38 variants across the ten populations. These
variants included 15 nonsynonymous SNPs and a 6 bp in-
del (i.e., the G2 variant [rs71785313]), which removed two
amino acids (i.e., p.Asn388_Tyr389del based on RefSeq
accession number NM_003661.3). Of the 15 nonsynony-
mous SNPs and one indel variant, eight were common var-
iants observed in at least six out of the ten populations,
and the FST estimates were highest among Africans (0.21)
at sites 1,228 and 1,356, which are in complete LD (i.e.,
the G1 allele; see Figure 2 and Table 1). Three of the 16 var-
iants occurred at the pore-forming domain, five occurred at
the membrane-addressing domain, and six, including the
G1 and G2 variants, occurred at the SRA-interacting
domain. Three nonsynonymous SNPs at sites 1,097,American Journal of Human Genetics 93, 54–66, July 11, 2013 57
Table 2. Genetic Diversity of APOL1 in Human African Populations
Ethnic Groups n S Sint Ssyn Sa qw Dint Dexon Dtotal
Cameroon
Fulani 38 17 10 2 5 0.0029 0.41 0.80 0.66
Lemande 36 19 11 2 6 0.0033 1.21 1.01 1.24
Mada 38 15 5 2 8 0.0026 0.05 1.44 1.07
Bakola 38 17 7 2 8 0.0029 0.17 0.04 0.11
Kenya
Borana 36 21 11 3 7 0.0036 0.59 0.50 0.60
Sengwer 38 18 9 2 7 0.0031 0.37 0.35 0.01
Nigeria
Yoruba 36 11 4 2 5 0.0019 0.12 0.06 0.01
Tanzania
Hadza 38 15 6 2 7 0.0026 0.04 0.62 0.39
Iraqw 38 22 10 2 10 0.0038 0.19 0.50 0.21
Sandawe 38 22 9 2 11 0.0038 0.47 1.10 0.92
Total 374 38 18 4 15 0.0041 0.73 0.71 0.79
Abbreviations are as follows: n, number of chromosomes; Sint, number of segre-
gating sites with intronic SNPs; Ssyn, number of segregating sites with synony-
mous SNPs; Sa, number of segregating sites with amino-acid-changing SNPs;
qw, Watterson’s estimate of heterozygosity; and Dint, Tajima’s D for introns;
Dexon, Tajima’s D for exons; and Dtotal, Tajima’s D for the total sequenced
region.1,258, and 1,354 were not present in dbSNP (build 137; see
Figure 2). Although this exon has been previously
sequenced in the Yoruba population,24 only 5 out of the
16 nonsynonymous variants identified in the current
study were observed in this population. Nucleotide diver-
sity estimated by Watterson’s qw ranges from 0.0019 to
0.0035 in these ten populations (Table 2), which makes it
>4-fold higher than the average qw estimated in exons
across the entire genome.44 In addition, 18 SNPs were
identified in the 518 bp intron region, and none were pre-
sent in dbSNP.
The G1 risk allele, which carries two derived nonsynon-
ymous variants (rs73885319 and rs60910145), was
observed in six out of ten populations: Bakola Pygmies
and Mada from Cameroon, Hadza, Iraqw, and Sandawe
from Tanzania, and Yoruba from Nigeria. The allele fre-
quency of G1 was highest in the Yoruba population
(39%), consistent with Genovese et al.,24 but was %5%
in each of the other five populations (Table 1). The G2 in-
del, another risk allele associated with CKD, was observed
in most populations except for the Hadza and Sandawe
hunter-gatherers from Tanzania and had allele frequencies
ranging from 3% to 8% (Table 1). We also identified three
additional nonsynonymous SNPs that occurred at the
same SRA-interacting domain as G1 and G2 (i.e., sites
1,258, 1,354, and 1,357; see Figure 2). The SNP at site
1,354 occurred at the same codon (but different nucleotide
sites) that codes for one of the two amino acid changes in58 The American Journal of Human Genetics 93, 54–66, July 11, 2013allele G1 but caused a different amino acid change
(p.Ile384Phe, RefSeq NM_003661.3). This variant was
observed only in the Iraqw and Sandawe from Tanzania
with allele frequencies of 3% and 5%, respectively. Allele
frequencies for the intron and synonymous SNPs in each
population are given in Table S3.
LD Patterns between Genetic Variants at APOL1
Patterns of LD were characterized by r2 estimates for all
pairwise comparisons for the polymorphic sites with mi-
nor allele frequencyR 3% in each of the ten populations.
The two G1 nonsynonymous SNPs that were 128 bp apart
from each other were in complete LD in each of the six
populations in which they were observed (Figure 3A). No
other variants were found in significant LD with these
two G1 SNPs at our resequenced region. No SNPs were
found significantly associated with the G2 allele either.
We further observed eight polymorphic sites in strong
LD in most populations except for the Yoruba (average r2
estimates ranged from 0.6 to 1.0; also see Figure 3A); they
form a haplotype that we hereafter refer to as the ‘‘G3’’
haplotype. Haplotype-network analysis indicated that the
G3 haplotype occurs on a branch that is highly divergent
from all other common haplotypes at APOL1 (Figure 3B).
The eight polymorphic sites that distinguish this haplo-
type are distributed across the 1.4 kb region and include
two synonymous SNPs (sites 858 and 1,164), two non-
synonymous SNPs at sites 888 (rs136175) and 968
(rs136176) located at the pore-forming domain and mem-
brane-addressing domain, respectively, and four intronic
SNPs (sites 243, 383, 471, and 474). In addition, one pop-
ulation-specific synonymous SNP at site 1,386 was found
to be strongly linked with five of the G3 SNPs (r2 ¼ 0.65
and p¼ 0.005 for each pairwise comparison) in the Borana
from Kenya (Figure 3A). An additional nonsynonymous
SNP at site 1,001 (rs142955744) was found in complete
LD with five of the G3 SNPs in the Sandawe population
(r2 ¼ 1 and p < 0.001 for each pairwise comparison). We
found the G3 haplotype to be most common in the Fulani
(21% in haplotype frequency), Bakola (11%), Sengwer
(11%), and Iraqw (13%) populations compared to other
populations (0%–5%). The detailed results of r2 estimates
for all pairwise comparisons between SNPs in each popula-
tion are provided in Table S4.
Identifying Signatures of Recent Adaptive Evolution
We first used Tajima’s D statistic, a summary statistic based
on the allele-frequency spectrum, to test for deviation from
neutral expectation. Our results showed no significant de-
parture from neutrality in the intron, exon, or full
sequence (Table 2). We further performed EHH and iHS an-
alyses to detect signatures of recent selection by character-
izing long-range patterns of LD for a subset of our sampled
individuals for whomwe had Illumina 1M SNP genotyping
data from the entire genome. The iHS and EHH statistics
were computed only for SNPs with a minor allele fre-
quency > 5%.37 As a result, the sample size for each
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A Figure 3. Heatmap of Pairwise LD and
Haplotype Network for the APOL1 Vari-
ants in African Populations
(A) Pairwise estimates of r2 between the
APOL1 variants. Each pixel represents a
pairwise LD measurement using the
squared correlation coefficient (r2). r2 was
measured for all possible pairs of polymor-
phic sites. Levels of LD ranging from 0 to 1
are illustrated according to a white-to-red
color gradient. The sequence position of
each variant is marked by a black line
segment on a diagonal line, and the posi-
tions for the G3 SNPs marked by asterisks
are labeled in blue. The sequence positions
(i.e., sites 1,228 and 1,356) of G1 SNPs are
labeled in black.
(B) Network analysis of the APOL1 haplo-
types. Each node represents a haplotype,
and the nodes representing the G1, G2,
and G3 haplotypes are labeled. The size
for a given node is proportional to its
haplotype frequency. The sequence posi-
tions of the eight SNPs that define the G3
haplotype (G3) are labeled.population was reduced (see Figure 4). Because of the small
sample size, the G2 risk allele was excluded from the EHH
and iHS analyses.
We identified outliers of iHS for SNPs within the 1.4 kb
resequenced region of APOL1 by comparing them to the
empirical iHS distributions estimated from the genome
for different frequency classes with a 95% cutoff threshold.
The plots of jiHSj statistics for SNPs located at APOL1 and
for flanking SNPs across an ~120 kb chromosomal region
encompassing APOL2 (MIM 607252), APOL1, and MHY9
are shown in Figure 4. Our results showed evidence of
adaptive selection on the G3 haplotype in the Fulani pop-
ulation, in which allele frequencies of all G3 SNPs were
larger than 20%. The jiHSj estimates fell outside the 95%
cutoff thresholds for most of the G3 variants, and the high-
est jiHSj (2.67) was at site 243 (Figure 4, also see Figure S1).
The EHH plots show that among the eight G3 SNPs, three
have EHH on chromosomes containing their derived al-
leles; site 968 (rs136176) is a nonsynonymous SNP located
at the membrane-addressing domain, and sites 383 and
1,164 are intronic and synonymous SNPs, respectively
(Figure 5A). For the other populations, we did not observe
any of the G3 SNPs outside of the 95% empirical-distribu-
tion thresholds. However, it is worth noting that allele fre-
quencies of these G3 SNPs were lower than 20% in most
populations except for the Fulani (Table 1 and Table S3),The American Journal of Hureducing our power to detect signa-
tures of selection by using iHS or
EHH analyses.37
For the G1 haplotype in the Yoruba
population, the EHH plot shows that
the derived allele has a longer
extended LD haplotype than the
ancestral allele (Figure 5B). However,the iHS of G1 (1.49) fell inside the 95% cutoff threshold
(Figure 4), showing some discrepancies between our result
and that of Genovese et al.24 For the other populations
(i.e., Bakola, Iraqw, and Sandawe), the allele frequencies
of G1 SNPs were %5% (Table 1). Finally, we identified
two adjacent intronic SNPs that were in strong LD (r2 ¼
0.663, p < 0.001) and that were outliers in the iHS analysis
in the Borana population from Kenya (jiHSj ¼ 2.0 and 2.4
for sites 164 and 297, respectively; see Figure 4). We
observed long-range LD extending only to the left side of
the two SNPs at positions 164 and 297. Fast LD decay
was observed on the right site of the EHH curve, correlating
with the location of a recombination hotspot according to
the recombination map of Kong et al.45 (Figure 5C). The
plots of EHH against genetic distance are given in
Figure S2. We also performed the McDonald-Kreitman
and dN/dS ratio tests for detecting signatures of natural se-
lection that might have occurred prior to the divergence of
human populations. We observed no significant deviation
from neutral expectation (Tables S5 and S6 and Figure S3).
Patterns of LD Decay at Low-Frequency Candidate
Variants
Whereas EHH and iHS analyses are usually sensitive for
detecting positive-selection signatures for intermediate-
frequency variants, we found the allele frequencies of theman Genetics 93, 54–66, July 11, 2013 59
Figure 4. Plots of iHS Values for SNPs of APOL1 and the Adjacent Chromosomal Regions in African Populations
The absolute values of standardized iHS (jiHSj) are plotted against the genomic positions (NCBI Genome browser build 36.1) of SNPs at
APOL1 and the neighboring genetic regions on chromosome 22 for a subset of our samples in each population. The number of chromo-
somes (n) is given for each population. The estimates of jiHSj are colored in red for the G1 SNPs and in orange for the G3 SNPs. The 95%
cutoff value (1.96) of the empirical distribution of standardized iHS is given in each plot (dashed line).G3 variants to be low (<20%) in many African populations
(Table 1 and Table S3). In order to further characterize LD
decay of the G3 haplotype in these populations, we plotted
r2 estimates between all SNPs (with allele frequencyR 3%)
against their physical distances across a 30 kb region flank-
ing the last exon of APOL1 for those individuals who had
resequencing and Illumina 1M SNP data. We then looked
at how far LD extended for the SNPs composing the G3
haplotype in comparison with the r2 distribution esti-
mated from the remaining SNPs. Figure 6 illustrates the
plots of LD decay for the six populations containing two
or more G3-associated SNPs in each population, and pair-
wise r2 is highlighted for each of the G3-associated SNPs.
In the Fulani population, more than 90% of r2 values
within the G3-associated SNPs showed higher LD than ex-
pected across a 15 kb region on the basis of the 95% predic-
tion interval. This pattern is consistent with the results of
the EHH analysis, which also showed unusual extended
long-range haplotype homozygosity for the G3 SNPs
(Figure 5A). Similarly, extended LD was also observed in
the Borana, Hadza, and Iraqw populations, in which
>90%, 100%, and 100% of r2 values, respectively, within
the G3-associated SNPs showed higher levels of LD than
expected on the basis of the 95% prediction interval in
each of the three populations. In contrast, we observed
no distinct LD patterns between the G3-associated SNPs
and the remaining SNPs in the Bakola and Sengwer popu-
lations. The LD-decay plots for the other four populations60 The American Journal of Human Genetics 93, 54–66, July 11, 2013(i.e., Lemande, Mada, Yoruba, and Sandawe) are given in
Figure S4.Discussion
Geographic Distribution of G1 and G2 CKD Risk
Alleles
Although the G1 allele of APOL1 has been identified as a
risk allele contributing to CKD susceptibility for individ-
uals of recent African descent, several studies have shown
that the G1 allele is common only in western Africa and
has the highest frequency (>40%) in the Yoruba from
Nigeria.46–48 In our study, we also found that the allele fre-
quency of G1 differs greatly between the Yoruba (38%) and
other populations (%5.3%, Table 1), consistent with previ-
ous findings. The high incidence of the G1 risk allele in
African Americans is in agreement with the finding of
Tishkoff et al.27 and Bryc et al.,49 who showed high levels
of West African ancestry in African Americans. In contrast,
although the G2 risk allele is present in most African pop-
ulations, allele frequencies are low (%8%).Evidence of Recent Darwinian Selection on APOL1
Variants
In this study, we identified an additional haplotype
(termed G3) that is highly divergent from the major haplo-
type groups at APOL1 in nine of the ten populations
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Figure 5. Decay of EHH for APOL1 Variants in Three African Pop-
ulations
The decay of EHH for the eight SNPs of the G3 haplotype in the
Fulani in Cameroon (A), for the G1 allele in the Yoruba in Nigeria
(B), and for the two intron SNPs identified as outliers in the iHS
analysis in the Borana in Kenya (C). The ancestral (anc) and
derived (drv) alleles that show unusual long-range haplotype ho-
mozygosity are labeled by their positions in our sequenced region
(see Figure 2). The sex-averaged standardized recombination rates
(labeled as ‘‘recomb rate’’ on the right y axis) in 10 kb bins are
plotted (in dashed line) against the chromosomal positions ac-
cording to Kong et al.45investigated (Figure 3B). Interestingly, none of the SNPs on
the G3 haplotype were found in the Yoruba. In the Fulani
population, long-range-LD analysis based on EHH and iHS
statistics showed that most G3 SNPs fall outside the 95% or
even 99% thresholds of the empirical distributions esti-
mated from the entire genome. These results suggest that
the G3 haplotype, or flanking region, might contain an
adaptive mutation (or mutations) that was favored by se-
lection, rapidly rose in frequency in the population, and
thus resulted in strong and locus-specific LD, a signature
of recent adaptive selection. The Fulani are predominantly
pastoralists (who practice cattle herding), making them
likely to have been subjected to severe HAT infections in
the past. Indeed, it has been suggested that HAT impacted
the migration history of the Fulani in the middle ages.50TheWe also identified two intronic SNPs (at sites 164 and 297
in strong LD) as outliers of iHS analysis in the Borana pop-
ulation from Kenya, although the unusual EHH was only
observed for the upstream region flanking these two sites
(Figure 5C). In fact, most of the EHH plots showed fast
drops in EHH values at our resequenced region (Figure 5).
It is notable that our resequenced region is less than 1 kb
from a recombination hotspot inferred to be 29-fold higher
than the average rate across the genome on the basis of
the recombination map of Kong et al.,45 who measured
recombination rates from directly observed recombination
events by using the SNP data of parent-offspring pairs (see
Figure 5C). This hotspot, however, was not identified in the
recombination map used in our analysis and was therefore
not taken into account during iHS computation (the
recombination map of Kong et al.45 could not be used for
computing the iHS for our analysis because of its low SNP
density at the region surrounding APOL1). Whereas the
actual boundary of this recombination hotspot remains
to be determined at a finer scale, the observed drastic drops
in the EHH plots imply that our resequenced region over-
laps the recombination hotspot. In other words, the
genetic distancemight be greatly underestimated at this re-
gion, and consequently, the iHS statistics might be under-
estimated for these APOL1 SNPs of interest. Therefore, our
inference of recent selection on the G3 haplotype in Fulani
appears to be conservative.
Additionally, our analysis showed a lower iHS for the G1
allele in the Yoruba population than did Genovese et al.,24
who observed no drastic drop in EHH at either side flank-
ing the G1 allele. This discrepancy can be at least partly
explained by the effects of this closely flanking or overlap-
ping recombination hotspot. Their data did not contain
many SNPs adjacent to the G1 SNPs, and consequently,
the recombination events were less likely to be detected
at this region. This is because two remote variants can be
in complete LD given that multiple recombination events
have occurred if the number of crossover events is even. In
such a case, we would expect no drop in EHH values be-
tween the two remote variants, similar to the EHH plot
shown in Genovese et al.24 The recombination events
can be better detected if the number of markers is increased
and can consequently cause drops in EHH, as observed
in our EHH plot for G1 in the Yoruba population
(Figure 5B). To test for this possible interpretation, we
repeated the EHH and iHS analyses by removing the in-
tronic SNPs at our resequenced region (see Figure 2). Subse-
quently, we no longer observed a drastic drop in EHH near
the G1 SNPs, and the jiHSj (1.92) became higher than the
former estimate (1.42) (see Figure S5 for the EHH plot of G1
after exclusion of intronic SNPs).
Selection Signatures for the Low-Frequency G3
Haplotype in the Borana, Hadza, and Iraqw
Populations
It has been shown that iHS analysis has limited statistical
power for positive selection influencing alleles at lowAmerican Journal of Human Genetics 93, 54–66, July 11, 2013 61
Figure 6. Decay of LD for the APOL1 Variants in African Populations
Plots of r2 estimates between polymorphic sites against the physical distance across a 30 kb region flanking the last exon of APOL1 in the
six African populations. The r2 estimates are colored in orange for all pairwise estimates within the G3-associated SNPs. In each plot, the
fitted nonlinear regression line (solid line) and its 95%prediction interval (dashed line) were plotted on the basis of all r2 estimates except
for the orange dots.frequency (<20%).37 In our study, only the Fulani popula-
tion had sufficiently high frequency for the G3 haplotype
(>20%) to obtain power to detect selection with the use of
iHS analysis. Frequencies of the G3 haplotype in the other
populations were less than 20%, making it difficult to
detect selection signatures with iHS or other statistical tests
based on the allele frequency spectrum, such as Tajima’s
D.37,51,52 To examine the pattern of LD decay at a fine scale
for the G3 haplotype, we plotted r2 estimates for the pair-
wise comparison between SNPs against their physical dis-
tances for a 30 kb region flanking the last exon of
APOL1. In addition to observing extended LD in the
Fulani, we also observed extended LD for the G3-associated
SNPs in the Borana, Hadza, and Iraqw populations relative
to the background level of LD (Figure 6).
Several possible evolutionary mechanisms can cause
elevated LD for a low-frequency haplotype in a population.
First, gene conversion is a commonmechanism in a multi-
gene family and results in genetic exchange between dupli-
cated genes that share high sequence homology. Gene
conversion occurs by transferring a segment of DNA
sequence from a donor to a recipient gene, and it can
thus cause local elevation of LD. For this reason, we tested
for gene conversion between APOL1 and its closest homo-
log, APOL2, but found no evidence of gene-conversion
events (see the detailed results in Figure S6). Second, recent
population admixture can also create LD between loci
regardless of their physical distances if allele frequencies
differ considerably between populations.53 Additionally,
migration events could introduce novel haplotypes into
a population, resulting in strong LD. Under such demo-
graphic scenarios, patterns of elevated LD are expected to
be genome-wide. However, our results of iHS analysis62 The American Journal of Human Genetics 93, 54–66, July 11, 2013have shown that the pattern of extended LD among the
G3 SNPs is a locus-specific rather than a genome-wide
pattern in the Fulani population. Similar patterns of
extended LD of the G3-associated SNPs were observed
across a 30 kb region in several ethnically and geographi-
cally diverse populations. These results are less likely to
be caused by multiple local-admixture events that intro-
duced the same haplotype. Finally, elevated LD can also
be observed for a young haplotype that arose recently in
a population under neutral evolutionary processes. How-
ever, we would not expect this young haplotype to be
found in many ethnically diverse populations across
eastern and western Africa. Together, the patterns of
extended LD of the G3 haplotype in these populations
cannot be easily explained by any of the neutral evolu-
tionary mechanisms without the invocation of recent ac-
tion of Darwinian selection.
Molecular Mechanisms of the Evolutionary Arms Race
between Humans and Trypanosomes
HAT is a devastating infectious disease in sub-Saharan Af-
rica and has a record of wiping out two-thirds of the pop-
ulation in Uganda during the period from 1900 to
1920.26 Human blood contains TLF, which belongs to
one group of HDL particles and is composed of hapto-
globin-related protein (Hpr) and APOL1. The current
model of APOL1-associated trypanolysis begins with TLF
uptake mediated by Hp-Hb receptors expressed by the
bloodstream form of trypanosomes. During the progress
of the endocytic pathway from endosome to lysosome,
the pH environment in the endosome changes from
neutral to acidic and causes the membrane-addressing
domain of APOL1 to adopt a conformational change that
results in the discharge of HDL. Subsequently, this APOL1
domain binds to the endosome membranes, where the
pore-forming domain of APOL1 forms a pore in the mem-
brane and triggers an irreversible influx of chloride ions
(Cl) and H2O from the cytoplasm into the lysosome,
causing osmotic swelling of this compartment and eventu-
ally leading to parasite death.29,54,55
Although TLF can effectively lyse trypanosomes, resis-
tance has been observed in two Trypanosoma subspecies,
T. b. rhodesiense and T. b gambiense, which cause eastern
and western forms of HAT, respectively.26,29 Expression
of SRA in T. b. rhodesiense, however, allows neutralization
of APOL1 via interaction with APOL1’s C-terminal a-helix
(encoded by the SRA-interacting domain) in the endosome
and results in the loss of trypanolytic activity.29 By
contrast, human serum samples that contain the G1 and
G2 genetic variants, which occur at the APOL1 region en-
coding the SRA-interacting domain of APOL1, regain the
trypanolytic activity of APOL1 to lyse SRA-positive T. b.
rhodesiense.24 In this study, we also identified three addi-
tional nonsynonymous changes at the SRA-interacting
domain of APOL1 (Figure 2). One change (p.Ile384Phe)
occurred at the same codon that codes for one of the two
amino acid changes of allele G1 (p.Ile384Met). All three
variants were only observed in East African populations
that are exposed to T. b. rhodesiense (Table 1). Each of the
three amino acid changes segregated in only one or two
populations with an allele frequency < 5%, suggesting
that these changes might be quite recent (Table 1). Because
of their low frequency, we did not have power to detect
whether selection is acting on these variants. However, it
would be of great interest to detect their functional conse-
quences on lysing the SRA-positive T. b. rhodesiense strains.
Despite the lack of SRA in T. b gambiense, this subspecies
also shows resistance to trypanolytic activity in human
blood, suggesting a resistance mechanism differing from
the SRA-mediated mechanism in T. b. rhodesiense.29
Although the resistance mechanism in T. b gambiense re-
mains elusive, we have identified candidate variants tar-
geted by recent adaptive selection on the G3 haplotype
in the Cameroonian Fulani population that is currently
exposed to T. b. gambiense infection. Selection signatures
at G3 were also observed in three eastern populations,
including Borana, Hadza, and Iraqw. The G3 haplotype
contains three derived SNPs; two derived SNPs are intronic
and synonymous at sites 383 and 1,164, and one occurs at
the membrane-addressing domain and causes an amino
acid change (p.Lys255Arg) in APOL1. Thus, this nonsy-
nonymous variant is a candidate for future studies of a po-
tential functional role in the mechanism of resistance
against T. b. gambiense and T. b. rhodesiense infection. Adap-
tation could also occur as a result of gene-expression
changes caused by a noncoding variant.56 Indeed, Keift
et al.57 proposed that a decrease in expression of the Hp-
Hb-receptor gene (TbgHpHbR) in trypanosomes might
contribute to parasite evasion of human TLF. Future studies
on the expression levels of APOL1 in G3-haplotype carriersThecould be informative for elucidating potential influence on
gene-expression regulation. However, it should be noted
that whereas genetic signatures of selection often reflect
a selection scheme that occurred in the past,58 functional
assays only allow detection of resistance against parasite
strains at the present time. The selection scheme is subject
to change over time under the model of an evolutionary
arms race between host and parasites.59 Additionally,
Smith and Malik40 have reported signatures of positive se-
lection at other APOL genes in primates and hypothesized
their possible antagonistic role against pathogen infection.
Natural selection could target functional variants at other
APOL genes, and these variants could be in strong LD
with the G3 haplotype or with other selected haplotypes
at APOL1.
Selection-Targeted Haplotypes as Potential Risk
Alleles Contributing to CKD Susceptibility
Whereas G1 and G2 have been identified as risk alleles
contributing to CKD susceptibility, the fact that the two al-
leles appear to have evolved adaptively in the Yoruba24,25
suggests that selective pressure of HAT might allow delete-
rious or mildly deleterious mutations to increase in fre-
quency if they can confer some protection.2,4,60 However,
we did not see a strong signature of selection of these loci
in other African populations that have low to moderate
allele frequencies. Furthermore, the T. rhodensiense parasite
is not currently common in Nigeria. These observations
raise the possibility that there might be differential levels
or patterns of selection across ethnically diverse Africans
spatially and temporally (e.g., the geographic distribution
of these parasite subspecies might have differed in the
past). Alternatively, additional selective pressures other
than resistance to T. rhodensiense might be influencing
allele-frequency distributions. In this study, we also identi-
fied adaptive-evolution signatures impacting several other
APOL1 variants, such as the G3 haplotype in the Fulani
population and the haplotype that carries two intronic
SNPs at sites 164 and 297 in the Borana population.
Whereas the actual functional variant(s) targeted by selec-
tion might be located elsewhere, these identified haplo-
types are candidates for future studies of association
between risk of CKD susceptibility and infectious disease
resistance in Africans.
It has been shown that African Americans have high
levels of ancestry from western Africa (particularly from
the Yoruba, in which the G3 haplotype is absent) but
that they have little Fulani ancestry.27,49 Therefore, the
G3 haplotype might not play a major role contributing
to CKD susceptibility in themajority of African Americans.
However, it could play a role in the susceptibility to CKD in
some African populations that harbor this haplotype. For a
better understanding of the genetic basis that underlies
CKD susceptibility in African Americans, it would be
important to identify additional common variants of
APOL1 in other West African populations that are likely
to be source populations for African Americans.American Journal of Human Genetics 93, 54–66, July 11, 2013 63
Supplemental Data
Supplemental Data include six figures and six tables and can be
found with this article at http://www.cell.com/AJHG/.Acknowledgments
We thank Joseph Lachance and two anonymous reviewers for
their valuable comments on the manuscript. We are grateful to
Charla Lambert for her assistance with the analyses of extended
haplotype homozygosity and integrated haplotype scores. We
thank Bill Beggs for his technical assistance. This research was
funded by National Science Foundation grants BCS-0196183 and
BCS-0827436 and National Institutes of Health (NIH) grants
5-R01-GM076637-05 and 8DP1ES022577-04 to S.A.T. This project
was funded in part with Federal funds from the Frederick
National Laboratory for Cancer Research, NIH, under contract
HHSN261200800001E. The content of this publication does not
necessarily reflect the views or policies of the Department of
Health and Human Services, nor does mention of trade names,
commercial products, or organizations imply endorsement by
the United States Government. This research was supported (in
part) by the Intramural Research Program of the NIH, Frederick
National Lab, Center for Cancer Research.
Received: January 7, 2013
Revised: April 10, 2013
Accepted: May 20, 2013
Published: June 13, 2013Web Resources
The URLs for data presented herein are as follows:
National Center for Biotechnology Information, http://www.ncbi.
nlm.nih.gov/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.orgAccession Numbers
The GenBank accession numbers for the APOL1 sequences
reported in this paper are KC339295–KC339481.References
1. Barreiro, L.B., and Quintana-Murci, L. (2010). From evolu-
tionary genetics to human immunology: how selection shapes
host defence genes. Nat. Rev. Genet. 11, 17–30.
2. Haldane, J.B.S. (1932). The Causes of Evolution (London:
Longmans, Green & Co.).
3. Pauling, L., Itano, H.A., andWells, I. (1949). Sickle cell anemia
a molecular disease. Science 110, 543–548.
4. Haldane, J.B.S. (1949). The Rate of Mutations of Human
Genes. Proceedings of the Eighth International Congress of
Genetics, 267–273.
5. Allison, A.C. (1954). Protection afforded by sickle-cell trait
against subtertian malareal infection. BMJ 1, 290–294.
6. Gilles, H.M., Fletcher, K.A., Hendrickse, R.G., Lindner, R.,
Reddy, S., and Allan, N. (1967). Glucose-6-phosphate-dehy-
drogenase deficiency, sickling, and malaria in African children
in South Western Nigeria. Lancet 1, 138–140.64 The American Journal of Human Genetics 93, 54–66, July 11, 20137. Luzzatto, L., Usanga, F.A., and Reddy, S. (1969). Glucose-6-
phosphate dehydrogenase deficient red cells: resistance to
infection by malarial parasites. Science 164, 839–842.
8. Akey, J.M., Eberle, M.A., Rieder, M.J., Carlson, C.S., Shriver,
M.D., Nickerson, D.A., and Kruglyak, L. (2004). Population
history and natural selection shape patterns of genetic varia-
tion in 132 genes. PLoS Biol. 2, e286.
9. Cagliani, R., Pozzoli, U., Forni, D., Cassinotti, A., Fumagalli,
M., Giani, M., Fichera, M., Lombardini, M., Ardizzone, S.,
Asselta, R., et al. (2013). Crohn’s disease Loci are common tar-
gets of protozoa-driven selection. Mol. Biol. Evol. 30, 1077–
1087.
10. Cowie, C.C., Port, F.K., Wolfe, R.A., Savage, P.J., Moll, P.P., and
Hawthorne, V.M. (1989). Disparities in incidence of diabetic
end-stage renal disease according to race and type of diabetes.
N. Engl. J. Med. 321, 1074–1079.
11. Kiberd, B.A., and Clase, C.M. (2002). Cumulative risk for
developing end-stage renal disease in the US population.
J. Am. Soc. Nephrol. 13, 1635–1644.
12. Kopp, J.B., and Winkler, C. (2003). HIV-associated nephropa-
thy in African Americans. Kidney Int. Suppl. 63, S43–S49.
13. Kitiyakara, C., Eggers, P., and Kopp, J.B. (2004). Twenty-one-
year trend in ESRD due to focal segmental glomerulosclerosis
in the United States. Am. J. Kidney Dis. 44, 815–825.
14. Toto, R.D. (2004). Proteinuria and hypertensive nephrosclero-
sis in African Americans. Kidney Int. Suppl. 66, S102–S104.
15. Tareen, N., Zadshir, A., Martins, D., Pan, D., Nicholas, S., and
Norris, K. (2005). Chronic kidney disease in African American
and Mexican American populations. Kidney Int. Suppl. 68,
S137–S140.
16. Coresh, J., Selvin, E., Stevens, L.A., Manzi, J., Kusek, J.W.,
Eggers, P., Van Lente, F., and Levey, A.S. (2007). Prevalence
of chronic kidney disease in the United States. JAMA 298,
2038–2047.
17. Ferna´ndez, M., Alarco´n, G.S., Calvo-Ale´n, J., Andrade, R.,
McGwin, G., Jr., Vila´, L.M., and Reveille, J.D.; LUMINA Study
Group. (2007). A multiethnic, multicenter cohort of patients
with systemic lupus erythematosus (SLE) as a model for the
study of ethnic disparities in SLE. Arthritis Rheum. 57,
576–584.
18. United State Renal Data System USRD. (2011). Annual Data
Report: Atlas of Chronic Kidney Disease and End-Stage Renal
Disease in the United States (Bethesda: National Institutes of
Health, National Institute of Diabetes and Digestive and Kid-
ney Diseases).
19. Cambien, F. (2011). Heritability, weak effects, and rare variants
in genomewide association studies. Clin. Chem. 57, 1263–
1266.
20. Chapman, S.J., and Hill, A.V.S. (2012). Human genetic suscep-
tibility to infectious disease. Nat. Rev. Genet. 13, 175–188.
21. Hardy, J., and Singleton, A. (2009). Genomewide association
studies and human disease. N. Engl. J. Med. 360, 1759–1768.
22. Juran, B.D., and Lazaridis, K.N. (2011). Genomics in the post-
GWAS era. Semin. Liver Dis. 31, 215–222.
23. Nelson, G.W., Freedman, B.I., Bowden, D.W., Langefeld, C.D.,
An, P., Hicks, P.J., Bostrom, M.A., Johnson, R.C., Kopp, J.B.,
and Winkler, C.A. (2010). Dense mapping of MYH9 localizes
the strongest kidney disease associations to the region of in-
trons 13 to 15. Hum. Mol. Genet. 19, 1805–1815.
24. Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L.,
Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D.,
Oleksyk, T.K., Uscinski Knob, A.L., et al. (2010). Association
of trypanolytic ApoL1 variants with kidney disease in African
Americans. Science 329, 841–845.
25. Tzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tare-
kegn, A., Bekele, E., Bradman, N., Wasser, W.G., Behar, D.M.,
and Skorecki, K. (2010). Missense mutations in the APOL1
gene are highly associated with end stage kidney disease risk
previously attributed to the MYH9 gene. Hum. Genet. 128,
345–350.
26. Lundkvist, G.B., Kristensson, K., and Bentivoglio, M. (2004).
Why trypanosomes cause sleeping sickness. Physiology (Be-
thesda) 19, 198–206.
27. Tishkoff, S.A., Reed, F.A., Friedlaender, F.R., Ehret, C., Ran-
ciaro, A., Froment, A., Hirbo, J.B., Awomoyi, A.A., Bodo,
J.M., Doumbo, O., et al. (2009). The genetic structure and his-
tory of Africans and African Americans. Science 324, 1035–
1044.
28. World Health Organization. (2000). WHO Report on
Global Surveillance of Epidemic-prone Infectious Diseases.
http://www.who.int/csr/resources/publications/surveillance/
a_tryps.pdf.
29. Pays, E., Vanhollebeke, B., Vanhamme, L., Paturiaux-Han-
ocq, F., Nolan, D.P., and Pe´rez-Morga, D. (2006). The trypa-
nolytic factor of human serum. Nat. Rev. Microbiol. 4,
477–486.
30. Stephens, M., and Donnelly, P. (2003). A comparison of
bayesian methods for haplotype reconstruction from pop-
ulation genotype data. Am. J. Hum. Genet. 73, 1162–
1169.
31. Stephens, M., Smith, N.J., and Donnelly, P. (2001). A new sta-
tistical method for haplotype reconstruction from population
data. Am. J. Hum. Genet. 68, 978–989.
32. Watterson, G.A. (1975). On the number of segregating sites in
genetical models without recombination. Theor. Popul. Biol.
7, 256–276.
33. Hartl, D.L., and Clark, A.G. (1997). Principles of population
genetics (Sunderland: Sinauer Associates).
34. Hill, W.G., and Robertson, A. (1968). Linkage disequilibrium
in finite populations. Theor. Appl. Genet. 38, 226–231.
35. Shin, J., Blay, S., McNeney, B., and Graham, J. (2006). LDheat-
map: An R Function for Graphical Display of Pairwise Linkage
Disequilibria between Single Nucleotide Polymorphisms.
J. Stat. Softw. 16, Code Snippet 3.
36. Sabeti, P.C., Reich, D.E., Higgins, J.M., Levine, H.Z.P., Richter,
D.J., Schaffner, S.F., Gabriel, S.B., Platko, J.V., Patterson, N.J.,
McDonald, G.J., et al. (2002). Detecting recent positive selec-
tion in the human genome from haplotype structure. Nature
419, 832–837.
37. Voight, B.F., Kudaravalli, S., Wen, X.Q., and Pritchard, J.K.
(2006). A map of recent positive selection in the human
genome. PLoS Biol. 4, e72.
38. Scheet, P., and Stephens, M. (2006). A fast and flexible statisti-
cal model for large-scale population genotype data: applica-
tions to inferring missing genotypes and haplotypic phase.
Am. J. Hum. Genet. 78, 629–644.
39. Sabeti, P.C., Walsh, E., Schaffner, S.F., Varilly, P., Fry, B., Hutch-
eson, H.B., Cullen, M., Mikkelsen, T.S., Roy, J., Patterson, N.,
et al. (2005). The case for selection at CCR5-Delta32. PLoS
Biol. 3, e378.
40. Smith, E.E., andMalik, H.S. (2009). The apolipoprotein L fam-
ily of programmed cell death and immunity genes rapidly
evolved in primates at discrete sites of host-pathogen interac-
tions. Genome Res. 19, 850–858.The41. Jarvis, J.P., Scheinfeldt, L.B., Soi, S., Lambert, C., Omberg, L.,
Ferwerda, B., Froment, A., Bodo, J.M., Beggs, W., Hoffman,
G., et al. (2012). Patterns of ancestry, signatures of natural se-
lection, and genetic association with stature in Western Afri-
can pygmies. PLoS Genet. 8, e1002641.
42. Verrelli, B.C., McDonald, J.H., Argyropoulos, G., Destro-Bisol,
G., Froment, A., Drousiotou, A., Lefranc, G., Helal, A.N., Loise-
let, J., and Tishkoff, S.A. (2002). Evidence for balancing selec-
tion from nucleotide sequence analyses of human G6PD. Am.
J. Hum. Genet. 71, 1112–1128.
43. Hudson, R.R. (2001). Linkage disequilibrium and recombina-
tion. In Handbook of statistical genetics, D. Balding, M.
Bishop, and C. Cannings, eds. (New York: John Wiley &
Sons), pp. 309–324.
44. Lachance, J., Vernot, B., Elbers, C.C., Ferwerda, B., Froment,
A., Bodo, J.M., Lema, G., Fu, W., Nyambo, T.B., Rebbeck,
T.R., et al. (2012). Evolutionary history and adaptation from
high-coverage whole-genome sequences of diverse African
hunter-gatherers. Cell 150, 457–469.
45. Kong, A., Thorleifsson, G., Gudbjartsson, D.F., Masson, G., Si-
gurdsson, A., Jonasdottir, A., Walters, G.B., Jonasdottir, A.,
Gylfason, A., Kristinsson, K.T., et al. (2010). Fine-scale recom-
bination rate differences between sexes, populations and indi-
viduals. Nature 467, 1099–1103.
46. Behar, D.M., Kedem, E., Rosset, S., Haileselassie, Y., Tzur, S.,
Kra-Oz, Z., Wasser, W.G., Shenhar, Y., Shahar, E., Hassoun,
G., et al. (2011). Absence of APOL1 risk variants protects
against HIV-associated nephropathy in the Ethiopian popula-
tion. Am. J. Nephrol. 34, 452–459.
47. Kopp, J.B., Nelson, G.W., Sampath, K., Johnson, R.C., Geno-
vese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S.,
et al. (2011). APOL1 genetic variants in focal segmental glo-
merulosclerosis and HIV-associated nephropathy. J. Am. Soc.
Nephrol. 22, 2129–2137.
48. Wasser, W.G., Tzur, S., Wolday, D., Adu, D., Baumstein, D.,
Rosset, S., and Skorecki, K. (2012). Population genetics of
chronic kidney disease: the evolving story of APOL1.
J. Nephrol. 25, 603–618.
49. Bryc, K., Velez, C., Karafet, T., Moreno-Estrada, A., Reynolds,
A., Auton, A., Hammer, M., Bustamante, C.D., and Ostrer,
H. (2010). Colloquium paper: genome-wide patterns of pop-
ulation structure and admixture among Hispanic/Latino
populations. Proc. Natl. Acad. Sci. USA 107(Suppl 2 ),
8954–8961.
50. Steverding, D. (2008). The history of African trypanosomiasis.
Parasit Vectors 1, 3.
51. Akashi, H. (1999). Inferring the fitness effects of DNA muta-
tions from polymorphism and divergence data: statistical po-
wer to detect directional selection under stationarity and free
recombination. Genetics 151, 221–238.
52. Grossman, S.R., Shlyakhter, I., Karlsson, E.K., Byrne, E.H., Mo-
rales, S., Frieden, G., Hostetter, E., Angelino, E., Garber, M.,
Zuk, O., et al. (2010). A composite of multiple signals distin-
guishes causal variants in regions of positive selection. Science
327, 883–886.
53. Hartl, D.L., and Clark, A.G. (2007). Principles of population
genetics (Sunderland: Sinauer Associates).
54. Vanhollebeke, B., and Pays, E. (2010). The trypanolytic factor
of human serum: many ways to enter the parasite, a single
way to kill. Mol. Microbiol. 76, 806–814.
55. Wheeler, R.J. (2010). The trypanolytic factor-mechanism, im-
pacts and applications. Trends Parasitol. 26, 457–464.American Journal of Human Genetics 93, 54–66, July 11, 2013 65
56. Tishkoff, S.A., Reed, F.A., Ranciaro, A., Voight, B.F., Babbitt,
C.C., Silverman, J.S., Powell, K., Mortensen, H.M., Hirbo,
J.B., Osman, M., et al. (2007). Convergent adaptation of hu-
man lactase persistence in Africa and Europe. Nat. Genet.
39, 31–40.
57. Kieft, R., Capewell, P., Turner, C.M., Veitch, N.J., MacLeod, A.,
and Hajduk, S. (2010). Mechanism of Trypanosoma brucei
gambiense (group 1) resistance to human trypanosome lytic
factor. Proc. Natl. Acad. Sci. USA 107, 16137–16141.
58. Sabeti, P.C., Schaffner, S.F., Fry, B., Lohmueller, J., Varilly, P.,
Shamovsky, O., Palma, A., Mikkelsen, T.S., Altshuler, D., and66 The American Journal of Human Genetics 93, 54–66, July 11, 2013Lander, E.S. (2006). Positive natural selection in the human
lineage. Science 312, 1614–1620.
59. Woolhouse, M.E., Webster, J.P., Domingo, E., Charlesworth,
B., and Levin, B.R. (2002). Biological and biomedical implica-
tions of the co-evolution of pathogens and their hosts. Nat.
Genet. 32, 569–577.
60. Ko, W.-Y., Gomez, F., and Tishkoff, S.A. (2012). Evolution of
human erythrocyte-specific genes involved in malaria suscep-
tibility. In Rapidly Evolving Genes and Genetic Systems, R.S.
Singh, J. Xu, and R.J. Kulathinal, eds. (Oxford: Oxford Univer-
sity Press), pp. 223–234.
